MintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural Implants
Summary
Unlike conventional implants, its compact, low-power chips enable modular designs adaptable to various neurological conditions, offering sensing, stimulation, and processing capabilities to enhance both functionality and accessibility. Martin Glen, Investment Director at Parkwalk Advisors, added: "MintNeuros innovative technology has the potential to change the lives of millions of patients suffering from a diverse range of neurological conditions. Strategic partnerships with leading institutions and medical device companies place MintNeuro at the forefront of adaptable systems addressing a range of neurological conditions, including epilepsy, movement disorders, and cognitive dysfunctions. Parkwalk invests in businesses creating solutions to real-world challenges, with IP-protected innovations, across a range of sectors including life sciences, AI, quantum computing, advanced materials, genomics, cleantech, future of mobility, medtech and big data. We also organize startup acceleration programs and have built an in-house VC to drive innovation across multiple industries where weve invested in hundreds of successful companies including Dropbox, Guardant Health, Honey, Lending Club, N26, PayPal, and Rappi.